May 8th 2024
A new study highlights the potential of lipoprotein apheresis for reducing cardiovascular events in patients with elevated Lp(a).
Exercise in Young Obese Children Reduces Blood Pressure, Improves Markers of Atherosclerosis
December 31st 2009This online CME program is based on a study that appeared online December 11, 2009 in the Journal of the American College of Cardiology, and is designed for primary care clinicians, cardiologists, endocrinologists, and other specialists who care for obese children.
The prognostic role of metabolic syndrome after myocardial infarction
September 24th 2008We evaluated the prognostic role of metabolic syndrome after myocardial infarction and found that metabolic syndrome correlated with an increased risk of cardiovascular events and death. The risk of developing diabetes decreased with weight loss in patients with metabolic syndrome. These results indicate that a more aggressive approach to the treatment of patients with metabolic syndrome, particularly with regard to changes in lifestyle, would be beneficial.
Thoracic and abdominal aorticatherosclerosis
It was not until Virchow identified the cellular contributions to thrombosis that physicians began to visualize arteries as dynamic tissues.
Lipoprotein particle numbers: A better index of coronary events than lipoprotein cholesterol?
September 17th 2008In a case-control substudy of the Veterans Affairs High-Density Lipoprotein Intervention Trial, therapy with gemfibrozil was shown to reduce the total number of low-density lipoprotein (LDL) particles, especially small, more oxidizable LDL particles, which was associated with a reduced risk of coronary heart disease (CHD) events. Gemfibrozil also increased small-sized high-density lipoprotein particle numbers, which also correlated with a decrease in CHD events. Notably, these changes in particle numbers were not associated with significant changes in lipoprotein cholesterol concentrations, which current guidelines have made the principal target of lipid therapy.
Prevalent atherosclerosis-Choose your biomarker
Circulating biomarkers have been used in cardiovascular medicine as predictors of incident or prevalent disease.